Show simple item record

dc.contributor.authorBick, Ulrich
dc.contributor.authorTrimboli, Rubina M.
dc.contributor.authorAthanasiou, Alexandra
dc.contributor.authorBalleyguier, Corinne
dc.contributor.authorBaltzer, Pascal A. T.
dc.contributor.authorBernathova, Maria
dc.contributor.authorBorbély, Krisztina
dc.contributor.authorBrkljacic, Boris
dc.contributor.authorCarbonaro, Luca A.
dc.contributor.authorClauser, Paola
dc.contributor.authorCassano, Enrico
dc.contributor.authorColin, Catherine
dc.contributor.authorEsen, Gul
dc.contributor.authorEvans, Andrew
dc.contributor.authorFallenberg, Eva M.
dc.contributor.authorFuchsjaeger, Michael H.
dc.contributor.authorGilbert, Fiona J.
dc.contributor.authorHelbich, Thomas H.
dc.contributor.authorHeywang-Köbrunner, Sylvia H.
dc.contributor.authorHerranz, Michel
dc.contributor.authorKinkel, Karen
dc.contributor.authorKilburn-Toppin, Fleur
dc.contributor.authorKuhl, Christiane K.
dc.contributor.authorLesaru, Mihai
dc.contributor.authorLobbes, Marc B. I.
dc.contributor.authorMann, Ritse M.
dc.contributor.authorMartincich, Laura
dc.contributor.authorPanizza, Pietro
dc.contributor.authorPediconi, Federica
dc.contributor.authorPijnappel, Ruud M.
dc.contributor.authorPinker, Katja
dc.contributor.authorSchiaffino, Simone
dc.contributor.authorSella, Tamar
dc.contributor.authorThomassin-Naggara, Isabelle
dc.contributor.authorTardivon, Anne
dc.contributor.authorOngeval, Chantal Van
dc.contributor.authorWallis, Matthew G.
dc.contributor.authorZackrisson, Sophia
dc.contributor.authorForrai, Gabor
dc.contributor.authorHerrero, Julia Camps
dc.contributor.authorSardanelli, Francesco
dc.description.abstractAbstract: We summarise here the information to be provided to women and referring physicians about percutaneous breast biopsy and lesion localisation under imaging guidance. After explaining why a preoperative diagnosis with a percutaneous biopsy is preferred to surgical biopsy, we illustrate the criteria used by radiologists for choosing the most appropriate combination of device type for sampling and imaging technique for guidance. Then, we describe the commonly used devices, from fine-needle sampling to tissue biopsy with larger needles, namely core needle biopsy and vacuum-assisted biopsy, and how mammography, digital breast tomosynthesis, ultrasound, or magnetic resonance imaging work for targeting the lesion for sampling or localisation. The differences among the techniques available for localisation (carbon marking, metallic wire, radiotracer injection, radioactive seed, and magnetic seed localisation) are illustrated. Type and rate of possible complications are described and the issue of concomitant antiplatelet or anticoagulant therapy is also addressed. The importance of pathological-radiological correlation is highlighted: when evaluating the results of any needle sampling, the radiologist must check the concordance between the cytology/pathology report of the sample and the radiological appearance of the biopsied lesion. We recommend that special attention is paid to a proper and tactful approach when communicating to the woman the need for tissue sampling as well as the possibility of cancer diagnosis, repeat tissue sampling, and or even surgery when tissue sampling shows a lesion with uncertain malignant potential (also referred to as “high-risk” or B3 lesions). Finally, seven frequently asked questions are answered.
dc.publisherSpringer Berlin Heidelberg
dc.rightsAttribution 4.0 International (CC BY 4.0)en
dc.subjectBreast lesion localisation
dc.subjectCore needle biopsy
dc.subjectFine-needle sampling
dc.subjectVacuum-assisted biopsy
dc.titleImage-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging
prism.publicationNameInsights into Imaging
dc.contributor.orcidSardanelli, Francesco [0000-0001-6545-9427]

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International (CC BY 4.0)
Except where otherwise noted, this item's licence is described as Attribution 4.0 International (CC BY 4.0)